Positive data for Neovasc study of stent-like angina device

Neovasc reports positive data from a study of its stent-like device to treat refractory angina were published in the New England Journal of Medicine.

Neovasc (NYSE:NVC) said its device to treat refractory angina – implanted much like a coronary stent – met the endpoints in a clinical trial involving 104 patients.

Neovasc Inc., New England Journal of Medicine

News Well, Clinical Trials, Cardiac Implants

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DWVoNg